Study of the benefits of Medication Therapy Management in people with long term diseases
Not Applicable
- Conditions
- Health Condition 1: I259- Chronic ischemic heart disease, unspecifiedHealth Condition 2: I10- Essential (primary) hypertensionHealth Condition 3: J453- Mild persistent asthmaHealth Condition 4: J41- Simple and mucopurulent chronic bronchitisHealth Condition 5: E118- Type 2 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2022/02/040445
- Lead Sponsor
- Sapna K Dongre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Inpatients of age > 18 years admitted to the medicine department
Patients with polypharmacy ( >5 prescription medications)
Patients suffering from one or more of the following conditions - Diabetes, Hypertension, Ischaemic Heart Disease, Asthma & COPD and Rheumatoid Arthritis
Exclusion Criteria
cancer patients
organ transplant recipients
patients suffering from psychological problem(s)
those who were unable to participate in the assessm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method medication related problems <br/ ><br>economic outcome <br/ ><br>Timepoint: 12 weeks, 24 weeks, 36 weeks
- Secondary Outcome Measures
Name Time Method complexity of prescription (MRCI questionnaire) <br/ ><br>adherence to medications by the patient (Drug Attitude Inventory) <br/ ><br>Changes in health status and function will be measured using kartz index <br/ ><br>Timepoint: once in 3 months for 9 months